Endogenous endothelin increases gallbladder tone and leads to acute cholecystitis in the Australian possum

Neurogastroenterology and Motility

Volumn 16, Issue 1, 2004, Pages 125-133

  Al Jiffry, B O ^a,d   Shaffer, E A ^b   Woods, C M ^a   Menadue, M ^a   Young, F ^a   Oliver, J ^a   Thomas, A C ^c   Toouli, J ^a   Saccone, G T P ^a  

^a FLINDERS UNIVERSITY   (Australia)

^b UNIVERSITY OF CALGARY   (Canada)

^c FLINDERS MEDICAL CENTRE   (Australia)

^d KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

Author keywords

Australian possum; Endothelins; Experimental acute cholecystitis; Gallbladder contraction; Lipopolysaccharide; Tezosentan

Indexed keywords

ENDOTHELIN; ENDOTHELIN RECEPTOR ANTAGONIST; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; SODIUM CHLORIDE; TEZOSENTAN;

ACUTE CHOLECYSTITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUSTRALIA; CONTROLLED STUDY; DOSE RESPONSE; EPITHELIUM CELL; ESCHERICHIA COLI; FEMALE; GALLBLADDER; IMMUNOREACTIVITY; LEUKOCYTE COUNT; MALE; NONHUMAN; OPOSSUM; PLASMA; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; CHOLECYSTITIS, ACUTE; DISEASE MODELS, ANIMAL; ENDOTHELINS; ESCHERICHIA COLI; FEMALE; GALLBLADDER; IMMUNOHISTOCHEMISTRY; LEUKOCYTE COUNT; LIPOPOLYSACCHARIDES; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; OPOSSUMS; PYRIDINES; TETRAZOLES; VASODILATOR AGENTS;

EID: 1342310147     PISSN: 13501925     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2982.2003.00459.x     Document Type: Article

References (32)

1. Gracie WA, Ransohoff DF. The natural history of silent gallstones. The innocent gallstones are not a myth. N Engl J Med 1982; 307: 798-800.
2. Johanning JM, Gruenberg JC. The changing face of cholecystectomy. Am Surg 1998; 64: 643-47, discussion 647-8.
3. Jones-Monahan K, Gruenberg JC. Chronic acalculous cholecystitis: changes in patient demographics and evaluation since the advent of laparoscopy. J Soc Laparoendoscopic Surgeons 1999; 3: 221-24.
4. Horton JD, Bilhartz LE. Gallstone disease and its complications. In: Feldman M, Sleisenger MH, Scharschmidt B, eds. Seisenger and Fordtran's Gastrointestinal and Liver Disease. 7th edn. Philadelphia: Saunders, 2002: 1065-90.
5. Camilleri M. Enteric nervous system disorders: genetic and molecular insights for the neurogastroenterologist. Neurogastroenterol Mot 2001; 13: 277-95.
6. Moummi C, Gullikson GW, Gaginella TS. Effect of endothelin-1 on guinea pig gallbladder smooth muscle in vitro. J Pharmacol Exp Ther 1992; 260: 549-53.
7. Cardozo AM, Koepp J, Dorleans-Juste P, Rae GA. Receptors mediating endothelin-1-induced contractions of rabbit gallbladder. J Cardiovasc Pharmacol 2000; 36(Suppl. 1): S264-6.
8. Al-Jiffry BO, Meedeniya ACB, Chen JW et al. Endothelin-1 induces contraction of human and Australian possum gallbladder in vitro. Regul Pept 2001; 102: 31-39.
9. Al-Jiffry BO, Toouli J, Saccone GTP. Endothelin-3 induces both human and opossum gallbladder contraction mediated mainly by endothelin-B receptor subtype in vitro. J Gastroenterol Hepatol 2002; 17: 324-31.
10. Huang SC, Lee MC, Wei CK et al. Endothelin receptors in human and guinea-pig gallbladder muscle. Regul Pept 2001; 98: 145-53.
11. Al-Jiffry BO, Chen JW, Toouli J et al. Endothelin-1 is a potent stimulator of gallbladder contraction in the Australian Brushed-Tailed possum (abstract). Gastroenterology 2000; 118: A298.
12. Housset C, Carayon A, Housset B et al. Endothelin-1 secretion by human gallbladder epithelial cells in primary culture. Lab Invest 1993; 69: 750-55.
13. McCartney SA, Greaves RRSH, Warner TD et al. Endothelin content, expression, and receptor type in normal and diseased human gallbladder. Dig Dis Sci 2002; 47: 1786-92.
14. Jivegard L, Svanvik J. Naloxone increases mucosal fluid secretion in the inflamed and distended feline gall bladder: evidence for a possible protective mechanism by endogenous opioids. Clin Sci 1998; 74: 219-23.
15. Kaminski DL, Andrus CH, German D et al. The role of prostanoids in the production of acute acalculous cholecystitis by platelet-activating factor. Annals Surg 1990; 212: 455-61.
16. Kaminski DL, Deshpande YG, Qualy J et al. The role of prostaglandins in feline experimental cholecystitis. Surgery 1985; 98: 760-68.
17. Kaminski DL, Deshpande YG, Li A et al. Gallbladder mucosal protein secretion during development of experimental cholecystitis. Dig Dis Sci 1995; 40: 1157-64.
18. Prystowsky JB, Rege RV. Neurogenic inflammation in cholecystitis. Dig Dis Sci 1997; 42: 1489-94.
19. Kaminski DL, Feinstein WK, Deshpande YG. The production of experimental cholecystitis by endotoxin. Prostaglandins 1994; 47: 233-45.
20. Cullen JJ, Maes EB, Aggrawal S, Conklin JL, Ephgrave KS, Mitros FA. Effect of endotoxin on opossum gallbladder motility: a model of acalculous cholecystitis. Ann Surg 2000; 232: 202-7.
21. Clozel M, Ramuz H, Clozel JP et al. Pharmacology of tezosentan, new endothelin receptor antagonist designed for parenteral use. J Pharmacol Expt Ther 1999; 290: 840-6.
22. Konomi H, Woods CM, Meedeniya ACB et al. Effect of diaspirin cross-linked hemoglobin on motor function of the duodenum and biliary system in the Australian Brush-tailed possum in vivo. J Pharmacol Expt Ther 2001; 296: 1067-73.
23. Kogire M, Inoue K, Higashide S et al. Protective effects of endothelin-1 on acute pancreatitis in rats. Dig Dis Sci 1995; 40: 1207-12.
24. Pinzani M, Milani S, De Franco R et al. Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology 1996; 110: 534-48.
25. McCartney SA, Ballinger AB, Vojnovic I, Farthing MJ, Warner TD. Endothelin in human inflammatory bowel disease: comparison to rat trinitrobenzenesulphonic acid-induced colitis. Life Sci 2002; 71: 1893-904.
26. Marceau F, Hess JF, Bachvarov DR. The B1 Receptor for kinins. Pharmacol Rev 1998; 50: 357-86.
27. Calixto JB, Cabrini DA, Ferreira J et al. Kinins in pain and inflammation. Pain 2000; 87: 1-5.
28. Myers SI. The role of eicosanoids in experimental and clinical gallbladder disease. Prostag Leukotr Ess 1992; 45: 167-80.
29. Simonson MS, Herman WH. Protein kinase C and protein tyrosine kinase activity contribute to mitogenic signaling by endothelin-1. J Biol Chem 1993; 268: 9347-57.
30. Ozaki S, Ohwaki K, Ihara M. Coexpression studies with endothelin receptor subtypes indicate the existence of intracellular cross-talk between ETA and ETB receptors. J Biochem (Tokyo) 1997; 121: 440-7.
31. Bruno CM, Neri S, Sciacca C et al. Plasma endothelin-1 levels in liver cirrhosis. Int J Clin Lab Res 2000; 30: 169-72.
32. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 1994; 46: 325-415.